Arnold C Hanish - Net Worth and Insider Trading
Arnold C Hanish Net Worth
The estimated net worth of Arnold C Hanish is at least $19 Million dollars as of 2024-04-20. Arnold C Hanish is the Chief Accounting Officer of Eli Lilly and Co and owns about 26,155 shares of Eli Lilly and Co (LLY) stock worth over $19 Million. Arnold C Hanish is the Director of Omeros Corp and owns about 12,400 shares of Omeros Corp (OMER) stock worth over $37,758. Arnold C Hanish is also the Director of Salarius Pharmaceuticals Inc and owns about 1,854 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $914. Details can be seen in Arnold C Hanish's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Arnold C Hanish has not made any transactions after 2023-05-22 and currently still holds the listed stock(s).
Transaction Summary of Arnold C Hanish
Arnold C Hanish Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arnold C Hanish owns 3 companies in total, including Salarius Pharmaceuticals Inc () , Omeros Corp () , and Eli Lilly and Co () .
Click here to see the complete history of Arnold C Hanish’s form 4 insider trades.
Insider Ownership Summary of Arnold C Hanish
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Salarius Pharmaceuticals Inc | 2022-06-03 | director | |
Omeros Corp | 2023-05-22 | director | |
Eli Lilly and Co | 2012-05-18 | Chief Accounting Officer |
Arnold C Hanish Latest Holdings Summary
Arnold C Hanish currently owns a total of 3 stocks. Among these stocks, Arnold C Hanish owns 26,155 shares of Eli Lilly and Co (LLY) as of May 18, 2012, with a value of $19 Million and a weighting of 99.8%. Arnold C Hanish owns 12,400 shares of Omeros Corp (OMER) as of May 22, 2023, with a value of $37,758 and a weighting of 0.2%. Arnold C Hanish also owns 1,854 shares of Salarius Pharmaceuticals Inc (SLRX) as of June 3, 2022, with a value of $914 and a weighting of 0%.
Latest Holdings of Arnold C Hanish
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
LLY | Eli Lilly and Co | 2012-05-18 | 26,155 | 726.31 | 18,996,638 |
OMER | Omeros Corp | 2023-05-22 | 12,400 | 3.05 | 37,758 |
SLRX | Salarius Pharmaceuticals Inc | 2022-06-03 | 1,854 | 0.49 | 914 |
Holding Weightings of Arnold C Hanish
Arnold C Hanish Form 4 Trading Tracker
According to the SEC Form 4 filings, Arnold C Hanish has made a total of 0 transactions in Eli Lilly and Co (LLY) over the past 5 years. The most-recent trade in Eli Lilly and Co is the sale of 1,295 shares on May 18, 2012, which brought Arnold C Hanish around $52,435.
According to the SEC Form 4 filings, Arnold C Hanish has made a total of 1 transactions in Omeros Corp (OMER) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Omeros Corp is the sale of 5,000 shares on May 22, 2023, which brought Arnold C Hanish around $32,300.
According to the SEC Form 4 filings, Arnold C Hanish has made a total of 9 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Salarius Pharmaceuticals Inc is the acquisition of 1,120 shares on June 3, 2022, which cost Arnold C Hanish around $5,040.
Insider Trading History of Arnold C Hanish
- 1
Arnold C Hanish Trading Performance
GuruFocus tracks the stock performance after each of Arnold C Hanish's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arnold C Hanish is -29.06%. GuruFocus also compares Arnold C Hanish's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arnold C Hanish within 3 months outperforms 3 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Arnold C Hanish's insider trading performs compared to the benchmark.
Performance of Arnold C Hanish
Average Return
13.14%
Outperforming Transactions
30%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 0.67 | -29.06 | 5.19 | 13.14 | -32.18 | -51.74 |
Relative Return to S&P 500(%) | 4.44 | -28.07 | 2.91 | -3.52 | -47.64 | -60.44 |
Arnold C Hanish Ownership Network
Ownership Network List of Arnold C Hanish
Ownership Network Relation of Arnold C Hanish
Arnold C Hanish Owned Company Details
What does Salarius Pharmaceuticals Inc do?
Who are the key executives at Salarius Pharmaceuticals Inc?
Arnold C Hanish is the director of Salarius Pharmaceuticals Inc. Other key executives at Salarius Pharmaceuticals Inc include Exec VP Finance & Interim CFO Mark J Rosenblum , director & Chief Executive Officer David J. Arthur , and Chief Financial Officer Scott Jordan .
Salarius Pharmaceuticals Inc () Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Salarius Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Salarius Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Salarius Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Salarius Pharmaceuticals Inc Insider Transactions
Arnold C Hanish Mailing Address
Above is the net worth, insider trading, and ownership report for Arnold C Hanish. You might contact Arnold C Hanish via mailing address: 201 Elliott Avenue West, Seattle Wa 98119.